Healthequity (HQY) Receivables (2014 - 2026)

Healthequity has reported Receivables for 13 years, with the latest figure at $122.2 million in Q3 2026.

• On a quarterly basis, Receivables rose 9.92% year-over-year to $122.2 million in Q3 2026; TTM through Jul 2026 was $122.2 million, a 9.92% increase from a year earlier, with the FY2026 full-year figure at $123.7 million, up 4.82% from the prior year.
• Receivables was $122.2 million for Q3 2026 at Healthequity, roughly flat from $122.0 million in the prior quarter.
• The five-year high for Receivables was $123.7 million in Q1 2026, with the low at $86.0 million in Q2 2022.
• Average Receivables over 5 years is $104.5 million, with a median of $106.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Receivables increased 21.83% in 2022, then rose 2.38% in 2023.
• Over 5 years, Receivables stood at $87.7 million in 2022, then gained by 9.65% to $96.2 million in 2023, then advanced by 10.95% to $106.7 million in 2024, then gained by 4.25% to $111.2 million in 2025, then climbed by 9.84% to $122.2 million in 2026.
• The last three Receivables figures came in at $122.2 million (Q3 2026), $122.0 million (Q2 2026), and $123.7 million (Q1 2026), per Business Quant data.